Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01508455 · ClinicalTrials.gov registry record · Phase 2
Open-Label, Safety, and Efficacy Study of Dexmedetomidine in Preterm Subjects Ages ≥28 Weeks to <36 Weeks Gestational Age
A Phase 2 study of Anesthesia, sponsored by Hospira, now a wholly owned subsidiary of Pfizer.
- Completed
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
- 4
- Study locations
NCT01508455: Completed Phase 2 study of Anesthesia, sponsored by Hospira, now a wholly owned subsidiary of Pfizer.
NCT01508455 is a Phase 2 study of Anesthesia that has completed, run by Hospira, now a wholly owned subsidiary of Pfizer. The registered enrollment target is 6 participants, below the 109,410-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01508455, a Phase 2 study of Anesthesia, has completed, sponsored by Hospira, now a wholly owned subsidiary of Pfizer.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
- 4
- Study locations
Study Summary
The primary objective of this study is to characterize the safety, and efficacy of Dexmedetomidine (DEX) administered as an intravenous (IV) loading dose followed by a continuous IV infusion in preterm subjects, ages ≥ 28 weeks through \< 36 weeks gestational age.
Conditions Studied
Interventions
- DRUG Midazolam
- DRUG Dexmedetomidine
- DRUG Morphine
- DRUG Fentanyl
Study Locations (4)
Kentucky
- - Louisville
Pennsylvania
- - Pittsburgh
South Carolina
- - Greenville
West Virginia
- - Morgantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2012-03 |
| Est. Completion | 2012-05 |
| Phase | Phase 2 |
What the finished NCT01508455 record still lists
NCT01508455 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 109,410-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Anesthesia appearing as the primary indexed condition, and to 4 interventions - of which Midazolam is the first listed.
NCT01508455 reports a single indexed study location in Kentucky, Pennsylvania, South Carolina.
Frequently Asked Questions
What is clinical trial NCT01508455 about?
NCT01508455 is a clinical study titled "Open-Label, Safety, and Efficacy Study of Dexmedetomidine in Preterm Subjects Ages ≥28 Weeks to <36 Weeks Gestational Age". The primary objective of this study is to characterize the safety, and efficacy of Dexmedetomidine (DEX) administered as an intravenous (IV) loading dose followed by a continuous IV infusion in preterm subjects, ages ≥ 28 weeks through \< 36 weeks gestational age.
What is the current status of trial NCT01508455?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2012-03. Estimated completion is 2012-05.
What conditions does trial NCT01508455 study?
This clinical trial studies the following conditions: Anesthesia.
What interventions are being tested in trial NCT01508455?
The interventions under investigation include: Midazolam (DRUG), Dexmedetomidine (DRUG), Morphine (DRUG), Fentanyl (DRUG).
Who is sponsoring clinical trial NCT01508455?
This trial is sponsored by Hospira, now a wholly owned subsidiary of Pfizer, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01508455 being conducted?
This trial has 4 study locations across Kentucky, Pennsylvania, South Carolina, West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anesthesia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01508455's enrollment target sits among peer trials
6 58th of 57 the lowest of 57 other Anesthesia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anesthesia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dose-Ranging Study of Intranasal Kovacaine Mist in Pediatric Subjects
COMPLETED · Phase 2
-
Dose-Escalation Safety and Pharmacokinetic Study of K305
COMPLETED · Phase 2
-
EEG Studies of Ketamine General Anesthesia
COMPLETED · Phase 2
-
Investigating Near-Threshold Perception During Anesthetic Sedation
COMPLETED · Phase 2
-
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
RECRUITING
-
Total Intravenous Versus Inhalational Anesthesia- A Geriatric Anesthesia Study
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia